fbpx
June 26, 2020

FDA Okays New Treatment for Dravet Syndrome FDA Okays New Treatment for Dravet Syndrome

The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla, Zogenix) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with […]
June 25, 2020

Marijuana for Migraine? Some Tentative Evidence Marijuana for Migraine? Some Tentative Evidence

Medical marijuana may have promise for managing headache pain, according to results from a small study conducted at the Jefferson Headache Center at Thomas Jefferson University. […]
June 25, 2020

Cumulative Brain Damage in Athletes Can Occur Without Concussion Cumulative Brain Damage in Athletes Can Occur Without Concussion

Even athletes who don’t experience concussion but suffer repeated jolts or falls inherent in contact sports can experience subtle and cumulative brain changes, new imaging research […]
June 24, 2020

Consistent Effects for Galcanezumab in Cluster Headache Consistent Effects for Galcanezumab in Cluster Headache

Galcanezumab (Emgality, Eli Lilly and Co), the humanized monoclonal antibody that targets calcitonin gene–related peptide (CGRP), provides consistent improvements over time for patients with episodic cluster […]
June 24, 2020

First Reported US Case of COVID-19 Linked to Guillain-Barré First Reported US Case of COVID-19 Linked to Guillain-Barré

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The first official US case of Guillain-Barré syndrome (GBS) associated with COVID-19 […]
June 23, 2020

More Than a Third of Migraineurs Use Opioids for Treatment More Than a Third of Migraineurs Use Opioids for Treatment

NEW YORK (Reuters Health) – Opioids continue to be used for the treatment of migraine in the U.S., contrary to practice guidelines, according to new findings. […]
June 22, 2020

Headache Day ‘Threshold’ for Chronic Migraine Called Into Question Headache Day ‘Threshold’ for Chronic Migraine Called Into Question

People with high-frequency episodic migraine and low-frequency chronic migraine may have similar treatment needs because characteristics of the two disorders overlap significantly, calling into question the […]
June 22, 2020

FDA OKs Implantable Neurostimulator for Intractable Low Back Pain FDA OKs Implantable Neurostimulator for Intractable Low Back Pain

The US Food and Drug Administration (FDA) has approved an implantable neurostimulation system (ReActiv8, Mainstay Medical) to treat intractable chronic low back pain associated with multifidus […]
June 19, 2020

Circadian Rhythm Changes Linked to Future Parkinson’s Risk Circadian Rhythm Changes Linked to Future Parkinson’s Risk

Abnormalities in circadian rhythm may represent an important feature in the very early stages of Parkinson’s disease before symptoms develop, a new study suggests. “We found […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0